Lazard Asset Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $42.3K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $0 | Sell |
|
|||||
|
2024
Q2 | $98K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $203K | Sell |
|
|||||
|
2022
Q4 | $576K | Sell |
|
|||||
|
2022
Q3 | $990K | Buy |
|
|||||
|
2022
Q2 | $230K | Sell |
|
|||||
|
2022
Q1 | $323K | Buy |
|
|||||
|
2021
Q4 | $317K | Buy |
|
|||||
|
2021
Q3 | $46K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $478K | Buy |
|